Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
Clinical trial NCT06429761 · RECRUITING
Trial details
- NCT number
- NCT06429761
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2026-10-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.